Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Alcohol Use Disorder and Behavior
NCT06199076Phase 2Terminated
- Sponsor
- Karolinska Institutet
- Start
- Oct 2023
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray in alcohol use disorder (AUD) (4 arms), sponsored by Karolinska Institutet. Primary endpoints: Prosocial behavior using a brief 2-trial dictator game task and Prosocial behavior using an extended dictator game task. Started Oct 2023; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06199076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06199076.